SCHEMBL2864569

SCHEMBL2864569

O=C(O)c1ccc2[nH]nc(-c3ccnc4ccccc34)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 5/20 0.52
MAPK1 P28482 8/20 0.52
MAPKAPK3 Q16644 3/20 0.52
MAPK6 Q16659 3/20 0.52
ITK Q08881 1/20 0.49
MAPK3 P27361 2/20 0.46
HDAC6 Q9UBN7 1/20 0.45
FLT3 P36888 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
CAMKK1 Q8N5S9 1/20 0.41
CAMKK2 Q96RR4 1/20 0.41
TGFBR1 P36897 2/20 0.40
MAPK14 Q16539 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2857271 0.86 MAPK1 (0.46) MAP2K4MAPK1MAPK3HDAC6FLT3
SCHEMBL2866791 0.80 MAP2K4 (0.69) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL4903778 0.79 MAP2K4 (0.51) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL2864256 0.78 MAP2K4 (0.52) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL2861551 0.77 L3MBTL1 (0.60) MEN1NPC1RAB9AKMT2A
SCHEMBL2867287 0.77 MAP2K4 (0.51) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL2867324 0.77 PIM1 (0.56) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL2861172 0.76 LRRK2 (0.61) MAP2K4MAPK1MAPKAPK3MAPK6ITK
SCHEMBL4895080 0.76 ITK (0.54) MAPK1ITKTGFBR1MAPK14NPC1
SCHEMBL27558623 0.76 TTK (0.43) MAPK1TGFBR1MAPK14NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPKAPK3 7/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885MAPK1 1/4885MAPKAPK3 12/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPKAPK3 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.